Dubai, United Arab Emirates, June 16, 2021:  The Dubai Health Authority (DHA) signed today a MoU with Enpy, a Dubai-based firm to explore the use of AI-powered device for remote-patient monitoring. 

 

Enpy is a start-up UAE company, based in Dubai, specializing in Medical Artificial Intelligence. It has designed the non-invasive innovative medical device. 

 

The MoU was signed by Dr Younis Kazim, CEO of Dubai Healthcare Corporation at the DHA and Sam Taleb, Chairman of the Board of Directors at Enpy at the DHA headquarters. 

 

Dr Kazim highlighted that DHA will continue to focus on research, innovation and implementation of smart technologies across all aspects of healthcare delivery and management. 

DHA plans to implement such technologies across its primary healthcare centres to foster its remote patient monitoring initiatives to empower patients, ensure they stay on-track with their health and to aid in early detection.  Remote-patient monitoring will also help healthcare professionals by providing them with vital patient data to ensure regular follow-up and better patient compliance.

 

Dr Kazim highlighted that the DHA keen to continue collaborating with firms locally and globally to implement healthcare technologies after an evidence-based analysis.

 

Sam Taleb said: “We embarked on making advanced AI based preventive healthcare easily accessible to all and we are proud of unique collaboration we have with the DHA and its Dubai Health Innovation Centre. We are delighted to be part of the great Innovation and Artificial Intelligence Hub that Dubai has become.” 

 

Epsy’s innovative all-in-one non-invasive medical device is paired with a smartphone/tablet application, it is powered by Artificial Intelligence and measures vital signs.  It is an all-in-one advanced AI-powered healthcare companion at home, combining integrated medical sensors, embedded electronics, and a unique user-interface to guide users regularly in making the best decisions for their health.